Diseases and canonical pathway enrichments are linked to liver cancer-related terms (e.g. liver carcinoma/hepatobiliary system cancer), and liver function terms (e.g. hepatic cholestasis/apelin liver signaling, Figures S10D-E) respectively, with other more general terms linked to cancer and inflammation (e.g. apoptosis, IL-3 signaling). Here, APLN is linked to hepatocellular carcinoma.